Bigelow Investment Advisors LLC Sells 579 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bigelow Investment Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,269 shares of the healthcare conglomerate's stock after selling 579 shares during the quarter. UnitedHealth Group comprises approximately 1.0% of Bigelow Investment Advisors LLC's investment portfolio, making the stock its 23rd biggest holding. Bigelow Investment Advisors LLC's holdings in UnitedHealth Group were worth $2,160,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Timber Creek Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. Timber Creek Capital Management LLC now owns 12,232 shares of the healthcare conglomerate's stock worth $6,188,000 after purchasing an additional 197 shares in the last quarter. Northcape Wealth Management LLC lifted its position in shares of UnitedHealth Group by 0.9% in the fourth quarter. Northcape Wealth Management LLC now owns 4,345 shares of the healthcare conglomerate's stock worth $2,198,000 after purchasing an additional 37 shares in the last quarter. Atlas Legacy Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $1,090,000. Bank of Jackson Hole Trust bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $1,371,000. Finally, Callahan Advisors LLC increased its holdings in UnitedHealth Group by 0.6% during the fourth quarter. Callahan Advisors LLC now owns 43,835 shares of the healthcare conglomerate's stock worth $22,174,000 after buying an additional 266 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 7.3 %

Shares of UnitedHealth Group stock traded down $36.84 on Friday, hitting $465.58. The stock had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. The firm has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a PEG ratio of 1.40 and a beta of 0.61. The stock has a 50 day moving average of $519.27 and a 200 day moving average of $560.54. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.